Sedana Medical AB (publ)
STO:SEDANA
Sedana Medical AB (publ)
Revenue
Sedana Medical AB (publ)
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Revenue
kr178.8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Revenue
kr18.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Revenue
kr884.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Revenue
kr723.2m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Getinge AB
STO:GETI B
|
Revenue
kr34.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Revenue
kr11.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Sedana Medical AB (publ)
Glance View
Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
See Also
What is Sedana Medical AB (publ)'s Revenue?
Revenue
178.8m
SEK
Based on the financial report for Dec 31, 2024, Sedana Medical AB (publ)'s Revenue amounts to 178.8m SEK.
What is Sedana Medical AB (publ)'s Revenue growth rate?
Revenue CAGR 5Y
20%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Sedana Medical AB (publ) have been 4% over the past three years , 20% over the past five years .
You don't have any saved screeners yet